MRNA ▲ +8.1% - Moderna, Inc. $MRNA | Moderna Q3 Earnings: - Rev: $1.31B (est $888.1M) - EPS: 38c (est loss/shr $1.09) - R&D Expenses: $583M (est $750M) - Sees FY Capex: $200M (prev saw $200M To $300M; est $244.1M) - Sees FY R&D Expenses: About $2.7B (prev saw About $2.9B) 06-NOV-2026 06:49 AM ET